Physician profile
Sundeep Bhambhani
NPI 1841504958
$3,244.69
in general payments reported to CMS, 2019-2025
19 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $830 · 2020: $214 · 2021: $445 · 2022: $730 · 2023: $370 · 2024: $261 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $729.21 | 2022-2025 | Xiidra, Miebo, Prolensa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $602.69 | 2019-2021 | |
| Alcon Vision LLC | $373.27 | 2019-2025 | Tryptyr, Rocklatan, Eysuvis |
| Johnson & Johnson Vision Care, INC. | $308.22 | 2019-2023 | Acuvue |
| Eyevance Pharmaceuticals LLC | $147.74 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $146.62 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $144.88 | 2019-2022 | |
| Coopervision INC. | $116.19 | 2019 | |
| Oyster Point Pharma, INC. | $108.51 | 2022-2025 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $107.29 | 2019-2025 | |
| Dompe US, INC. | $91.18 | 2021-2025 | Oxervate |
| Abbvie INC. | $86.62 | 2022-2023 | Alphagan P, Lumigan, Vuity |
| Thea Pharma INC. | $73.93 | 2022-2023 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $65.59 | 2024 | Xdemvy |
| Allergan, INC. | $51.51 | 2020-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $35.47 | 2023 | Lipiflow System Activator (Disposable) |
| Optos, INC. | $22.42 | 2022 | |
| Shire North American Group INC | $17.52 | 2019 | |
| Quidel Corporation | $15.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sundeep Bhambhani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.